Skip to content

Application of PET-CT in the diagnosis of autoimmune encephalitis

Application of PET-CT in the diagnosis of autoimmune encephalitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066920
Enrollment
Unknown
Registered
2022-12-21
Start date
2021-10-22
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune encephalitis

Interventions

Sponsors

Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with autoimmune encephalitis according to clinical norms or diagnostic criteria and undergoing PET-CT scanning contain autoimmune encephalitis with antibody positive and antibody negative.

Exclusion criteria

Exclusion criteria: Central nervous system diseases with definite diagnosis leading to epilepsy, cognitive impairment or abnormal mental symptoms, including Alzheimer's disease, Parkinson's disease, central nervous system tumors, schizophrenia, etc. However, patients with other systemic tumor diseases should not be excluded. Lactating and / or pregnant women. Patients who cannot cooperate with the examination due to serious mental and behavioral abnormalities and central respiratory failure.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Secondary

MeasureTime frame
Accuracy;Positive Predictive Value;Glucose metabolism level;

Countries

China

Contacts

Public ContactYong Hao
yhao23@126.com+86 13761692721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026